Tag: New Drug Durvalumab

Patients with an aggressive form of bladder cancer may now have an increased chance of survival thanks to a new drug, durvalumab. Studies indicate that this immune-boosting medication can halt the progression of muscle-invasive bladder cancer and prevent further hospitalisations. Recently, the NHS spending watchdog granted approval for the rollout of durvalumab on the NHS,…